 | • レポートコード：QYR2104Z0775 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、94ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、バイオバーデン試験のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（機器、消耗品）、用途別市場規模（製薬、バイオテクノロジー、CMO）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・バイオバーデン試験の市場動向 ・企業の競争状況、市場シェア ・バイオバーデン試験の種類別市場規模（機器、消耗品） ・バイオバーデン試験の用途別市場規模（製薬、バイオテクノロジー、CMO） ・バイオバーデン試験の北米市場規模2016-2027（アメリカ、カナダ） ・バイオバーデン試験のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・バイオバーデン試験のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・バイオバーデン試験の中南米市場規模2016-2027（メキシコ、ブラジル） ・バイオバーデン試験の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Charles River Laboratories International、Sigma-Aldrich、SGS、Wuxi Pharmatech (CAYMAN)、Merck、Becton Dickinson、North American Science Associates Inc.、Nelson Laboratories、Pacific Biolabs、ATS Labs） ・結論 |
Bioburden testing is a process of measuring viable microorganisms on medical devices, raw material, or package. The process helps in determining parameters for its sterilization process to ensure safety and effectiveness of medical devices.
Market Analysis and Insights: Global Bioburden Testing Market
The global Bioburden Testing market size is projected to reach US$ 898.9 million by 2026, from US$ 555.7 million in 2019, at a CAGR of 7.0% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Bioburden Testing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Bioburden Testing market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Bioburden Testing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Bioburden Testing market.
Global Bioburden Testing Scope and Market Size
Bioburden Testing market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Bioburden Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Instruments
Consumables
Segment by Application
Pharmaceutical
Biotechnology
CMO
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Charles River Laboratories International
Sigma-Aldrich
SGS
Wuxi Pharmatech (CAYMAN)
Merck
Becton Dickinson
North American Science Associates Inc.
Nelson Laboratories
Pacific Biolabs
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Bioburden Testing Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Instruments
1.2.3 Consumables
1.3 Market by Application
1.3.1 Global Bioburden Testing Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Pharmaceutical
1.3.3 Biotechnology
1.3.4 CMO
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Bioburden Testing Market Perspective (2016-2027)
2.2 Bioburden Testing Growth Trends by Regions
2.2.1 Bioburden Testing Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Bioburden Testing Historic Market Share by Regions (2016-2021)
2.2.3 Bioburden Testing Forecasted Market Size by Regions (2022-2027)
2.3 Bioburden Testing Industry Dynamic
2.3.1 Bioburden Testing Market Trends
2.3.2 Bioburden Testing Market Drivers
2.3.3 Bioburden Testing Market Challenges
2.3.4 Bioburden Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Bioburden Testing Players by Revenue
3.1.1 Global Top Bioburden Testing Players by Revenue (2016-2021)
3.1.2 Global Bioburden Testing Revenue Market Share by Players (2016-2021)
3.2 Global Bioburden Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Bioburden Testing Revenue
3.4 Global Bioburden Testing Market Concentration Ratio
3.4.1 Global Bioburden Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Bioburden Testing Revenue in 2020
3.5 Bioburden Testing Key Players Head office and Area Served
3.6 Key Players Bioburden Testing Product Solution and Service
3.7 Date of Enter into Bioburden Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Bioburden Testing Breakdown Data by Type
4.1 Global Bioburden Testing Historic Market Size by Type (2016-2021)
4.2 Global Bioburden Testing Forecasted Market Size by Type (2022-2027)
5 Bioburden Testing Breakdown Data by Application
5.1 Global Bioburden Testing Historic Market Size by Application (2016-2021)
5.2 Global Bioburden Testing Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Bioburden Testing Market Size (2016-2027)
6.2 North America Bioburden Testing Market Size by Type
6.2.1 North America Bioburden Testing Market Size by Type (2016-2021)
6.2.2 North America Bioburden Testing Market Size by Type (2022-2027)
6.2.3 North America Bioburden Testing Market Size by Type (2016-2027)
6.3 North America Bioburden Testing Market Size by Application
6.3.1 North America Bioburden Testing Market Size by Application (2016-2021)
6.3.2 North America Bioburden Testing Market Size by Application (2022-2027)
6.3.3 North America Bioburden Testing Market Size by Application (2016-2027)
6.4 North America Bioburden Testing Market Size by Country
6.4.1 North America Bioburden Testing Market Size by Country (2016-2021)
6.4.2 North America Bioburden Testing Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Bioburden Testing Market Size (2016-2027)
7.2 Europe Bioburden Testing Market Size by Type
7.2.1 Europe Bioburden Testing Market Size by Type (2016-2021)
7.2.2 Europe Bioburden Testing Market Size by Type (2022-2027)
7.2.3 Europe Bioburden Testing Market Size by Type (2016-2027)
7.3 Europe Bioburden Testing Market Size by Application
7.3.1 Europe Bioburden Testing Market Size by Application (2016-2021)
7.3.2 Europe Bioburden Testing Market Size by Application (2022-2027)
7.3.3 Europe Bioburden Testing Market Size by Application (2016-2027)
7.4 Europe Bioburden Testing Market Size by Country
7.4.1 Europe Bioburden Testing Market Size by Country (2016-2021)
7.4.2 Europe Bioburden Testing Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Bioburden Testing Market Size (2016-2027)
8.2 Asia-Pacific Bioburden Testing Market Size by Type
8.2.1 Asia-Pacific Bioburden Testing Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Bioburden Testing Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Bioburden Testing Market Size by Type (2016-2027)
8.3 Asia-Pacific Bioburden Testing Market Size by Application
8.3.1 Asia-Pacific Bioburden Testing Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Bioburden Testing Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Bioburden Testing Market Size by Application (2016-2027)
8.4 Asia-Pacific Bioburden Testing Market Size by Region
8.4.1 Asia-Pacific Bioburden Testing Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Bioburden Testing Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Bioburden Testing Market Size (2016-2027)
9.2 Latin America Bioburden Testing Market Size by Type
9.2.1 Latin America Bioburden Testing Market Size by Type (2016-2021)
9.2.2 Latin America Bioburden Testing Market Size by Type (2022-2027)
9.2.3 Latin America Bioburden Testing Market Size by Type (2016-2027)
9.3 Latin America Bioburden Testing Market Size by Application
9.3.1 Latin America Bioburden Testing Market Size by Application (2016-2021)
9.3.2 Latin America Bioburden Testing Market Size by Application (2022-2027)
9.3.3 Latin America Bioburden Testing Market Size by Application (2016-2027)
9.4 Latin America Bioburden Testing Market Size by Country
9.4.1 Latin America Bioburden Testing Market Size by Country (2016-2021)
9.4.2 Latin America Bioburden Testing Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Bioburden Testing Market Size (2016-2027)
10.2 Middle East & Africa Bioburden Testing Market Size by Type
10.2.1 Middle East & Africa Bioburden Testing Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Bioburden Testing Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Bioburden Testing Market Size by Type (2016-2027)
10.3 Middle East & Africa Bioburden Testing Market Size by Application
10.3.1 Middle East & Africa Bioburden Testing Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Bioburden Testing Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Bioburden Testing Market Size by Application (2016-2027)
10.4 Middle East & Africa Bioburden Testing Market Size by Country
10.4.1 Middle East & Africa Bioburden Testing Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Bioburden Testing Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Charles River Laboratories International
11.1.1 Charles River Laboratories International Company Details
11.1.2 Charles River Laboratories International Business Overview
11.1.3 Charles River Laboratories International Bioburden Testing Introduction
11.1.4 Charles River Laboratories International Revenue in Bioburden Testing Business (2016-2021)
11.1.5 Charles River Laboratories International Recent Development
11.2 Sigma-Aldrich
11.2.1 Sigma-Aldrich Company Details
11.2.2 Sigma-Aldrich Business Overview
11.2.3 Sigma-Aldrich Bioburden Testing Introduction
11.2.4 Sigma-Aldrich Revenue in Bioburden Testing Business (2016-2021)
11.2.5 Sigma-Aldrich Recent Development
11.3 SGS
11.3.1 SGS Company Details
11.3.2 SGS Business Overview
11.3.3 SGS Bioburden Testing Introduction
11.3.4 SGS Revenue in Bioburden Testing Business (2016-2021)
11.3.5 SGS Recent Development
11.4 Wuxi Pharmatech (CAYMAN)
11.4.1 Wuxi Pharmatech (CAYMAN) Company Details
11.4.2 Wuxi Pharmatech (CAYMAN) Business Overview
11.4.3 Wuxi Pharmatech (CAYMAN) Bioburden Testing Introduction
11.4.4 Wuxi Pharmatech (CAYMAN) Revenue in Bioburden Testing Business (2016-2021)
11.4.5 Wuxi Pharmatech (CAYMAN) Recent Development
11.5 Merck
11.5.1 Merck Company Details
11.5.2 Merck Business Overview
11.5.3 Merck Bioburden Testing Introduction
11.5.4 Merck Revenue in Bioburden Testing Business (2016-2021)
11.5.5 Merck Recent Development
11.6 Becton Dickinson
11.6.1 Becton Dickinson Company Details
11.6.2 Becton Dickinson Business Overview
11.6.3 Becton Dickinson Bioburden Testing Introduction
11.6.4 Becton Dickinson Revenue in Bioburden Testing Business (2016-2021)
11.6.5 Becton Dickinson Recent Development
11.7 North American Science Associates Inc.
11.7.1 North American Science Associates Inc. Company Details
11.7.2 North American Science Associates Inc. Business Overview
11.7.3 North American Science Associates Inc. Bioburden Testing Introduction
11.7.4 North American Science Associates Inc. Revenue in Bioburden Testing Business (2016-2021)
11.7.5 North American Science Associates Inc. Recent Development
11.8 Nelson Laboratories
11.8.1 Nelson Laboratories Company Details
11.8.2 Nelson Laboratories Business Overview
11.8.3 Nelson Laboratories Bioburden Testing Introduction
11.8.4 Nelson Laboratories Revenue in Bioburden Testing Business (2016-2021)
11.8.5 Nelson Laboratories Recent Development
11.9 Pacific Biolabs
11.9.1 Pacific Biolabs Company Details
11.9.2 Pacific Biolabs Business Overview
11.9.3 Pacific Biolabs Bioburden Testing Introduction
11.9.4 Pacific Biolabs Revenue in Bioburden Testing Business (2016-2021)
11.9.5 Pacific Biolabs Recent Development
11.10 ATS Labs
11.10.1 ATS Labs Company Details
11.10.2 ATS Labs Business Overview
11.10.3 ATS Labs Bioburden Testing Introduction
11.10.4 ATS Labs Revenue in Bioburden Testing Business (2016-2021)
11.10.5 ATS Labs Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Bioburden Testing Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Instruments
Table 3. Key Players of Consumables
Table 4. Global Bioburden Testing Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Bioburden Testing Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Bioburden Testing Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Bioburden Testing Market Share by Regions (2016-2021)
Table 8. Global Bioburden Testing Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Bioburden Testing Market Share by Regions (2022-2027)
Table 10. Bioburden Testing Market Trends
Table 11. Bioburden Testing Market Drivers
Table 12. Bioburden Testing Market Challenges
Table 13. Bioburden Testing Market Restraints
Table 14. Global Bioburden Testing Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Bioburden Testing Market Share by Players (2016-2021)
Table 16. Global Top Bioburden Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bioburden Testing as of 2020)
Table 17. Ranking of Global Top Bioburden Testing Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Bioburden Testing Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Bioburden Testing Product Solution and Service
Table 21. Date of Enter into Bioburden Testing Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Bioburden Testing Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Bioburden Testing Revenue Market Share by Type (2016-2021)
Table 25. Global Bioburden Testing Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Bioburden Testing Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Bioburden Testing Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Bioburden Testing Revenue Market Share by Application (2016-2021)
Table 29. Global Bioburden Testing Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Bioburden Testing Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Bioburden Testing Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Bioburden Testing Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Bioburden Testing Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Bioburden Testing Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Bioburden Testing Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Bioburden Testing Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Bioburden Testing Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Bioburden Testing Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Bioburden Testing Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Bioburden Testing Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Bioburden Testing Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Bioburden Testing Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Bioburden Testing Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Bioburden Testing Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Bioburden Testing Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Bioburden Testing Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Bioburden Testing Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Bioburden Testing Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Bioburden Testing Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Bioburden Testing Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Bioburden Testing Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Bioburden Testing Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Bioburden Testing Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Bioburden Testing Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Bioburden Testing Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Bioburden Testing Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Bioburden Testing Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Bioburden Testing Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Bioburden Testing Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Bioburden Testing Market Size by Country (2022-2027) & (US$ Million)
Table 61. Charles River Laboratories International Company Details
Table 62. Charles River Laboratories International Business Overview
Table 63. Charles River Laboratories International Bioburden Testing Product
Table 64. Charles River Laboratories International Revenue in Bioburden Testing Business (2016-2021) & (US$ Million)
Table 65. Charles River Laboratories International Recent Development
Table 66. Sigma-Aldrich Company Details
Table 67. Sigma-Aldrich Business Overview
Table 68. Sigma-Aldrich Bioburden Testing Product
Table 69. Sigma-Aldrich Revenue in Bioburden Testing Business (2016-2021) & (US$ Million)
Table 70. Sigma-Aldrich Recent Development
Table 71. SGS Company Details
Table 72. SGS Business Overview
Table 73. SGS Bioburden Testing Product
Table 74. SGS Revenue in Bioburden Testing Business (2016-2021) & (US$ Million)
Table 75. SGS Recent Development
Table 76. Wuxi Pharmatech (CAYMAN) Company Details
Table 77. Wuxi Pharmatech (CAYMAN) Business Overview
Table 78. Wuxi Pharmatech (CAYMAN) Bioburden Testing Product
Table 79. Wuxi Pharmatech (CAYMAN) Revenue in Bioburden Testing Business (2016-2021) & (US$ Million)
Table 80. Wuxi Pharmatech (CAYMAN) Recent Development
Table 81. Merck Company Details
Table 82. Merck Business Overview
Table 83. Merck Bioburden Testing Product
Table 84. Merck Revenue in Bioburden Testing Business (2016-2021) & (US$ Million)
Table 85. Merck Recent Development
Table 86. Becton Dickinson Company Details
Table 87. Becton Dickinson Business Overview
Table 88. Becton Dickinson Bioburden Testing Product
Table 89. Becton Dickinson Revenue in Bioburden Testing Business (2016-2021) & (US$ Million)
Table 90. Becton Dickinson Recent Development
Table 91. North American Science Associates Inc. Company Details
Table 92. North American Science Associates Inc. Business Overview
Table 93. North American Science Associates Inc. Bioburden Testing Product
Table 94. North American Science Associates Inc. Revenue in Bioburden Testing Business (2016-2021) & (US$ Million)
Table 95. North American Science Associates Inc. Recent Development
Table 96. Nelson Laboratories Company Details
Table 97. Nelson Laboratories Business Overview
Table 98. Nelson Laboratories Revenue in Bioburden Testing Business (2016-2021) & (US$ Million)
Table 99. Nelson Laboratories Recent Development
Table 100. Pacific Biolabs Company Details
Table 101. Pacific Biolabs Business Overview
Table 102. Pacific Biolabs Bioburden Testing Product
Table 103. Pacific Biolabs Revenue in Bioburden Testing Business (2016-2021) & (US$ Million)
Table 104. Pacific Biolabs Recent Development
Table 105. ATS Labs Company Details
Table 106. ATS Labs Business Overview
Table 107. ATS Labs Bioburden Testing Product
Table 108. ATS Labs Revenue in Bioburden Testing Business (2016-2021) & (US$ Million)
Table 109. ATS Labs Recent Development
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Bioburden Testing Market Share by Type: 2020 VS 2027
Figure 2. Instruments Features
Figure 3. Consumables Features
Figure 4. Global Bioburden Testing Market Share by Application: 2020 VS 2027
Figure 5. Pharmaceutical Case Studies
Figure 6. Biotechnology Case Studies
Figure 7. CMO Case Studies
Figure 8. Bioburden Testing Report Years Considered
Figure 9. Global Bioburden Testing Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Bioburden Testing Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Bioburden Testing Market Share by Regions: 2020 VS 2027
Figure 12. Global Bioburden Testing Market Share by Regions (2022-2027)
Figure 13. Global Bioburden Testing Market Share by Players in 2020
Figure 14. Global Top Bioburden Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bioburden Testing as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Bioburden Testing Revenue in 2020
Figure 16. Global Bioburden Testing Revenue Market Share by Type (2016-2021)
Figure 17. Global Bioburden Testing Revenue Market Share by Type (2022-2027)
Figure 18. North America Bioburden Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Bioburden Testing Market Share by Type (2016-2027)
Figure 20. North America Bioburden Testing Market Share by Application (2016-2027)
Figure 21. North America Bioburden Testing Market Share by Country (2016-2027)
Figure 22. United States Bioburden Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Bioburden Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Bioburden Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Bioburden Testing Market Share by Type (2016-2027)
Figure 26. Europe Bioburden Testing Market Share by Application (2016-2027)
Figure 27. Europe Bioburden Testing Market Share by Country (2016-2027)
Figure 28. Germany Bioburden Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Bioburden Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Bioburden Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Bioburden Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Bioburden Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Bioburden Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Bioburden Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Bioburden Testing Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Bioburden Testing Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Bioburden Testing Market Share by Region (2016-2027)
Figure 38. China Bioburden Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Bioburden Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Bioburden Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Bioburden Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Bioburden Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Bioburden Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Bioburden Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Bioburden Testing Market Share by Type (2016-2027)
Figure 46. Latin America Bioburden Testing Market Share by Application (2016-2027)
Figure 47. Latin America Bioburden Testing Market Share by Country (2016-2027)
Figure 48. Mexico Bioburden Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Bioburden Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Bioburden Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Bioburden Testing Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Bioburden Testing Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Bioburden Testing Market Share by Country (2016-2027)
Figure 54. Turkey Bioburden Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Bioburden Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Bioburden Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Charles River Laboratories International Revenue Growth Rate in Bioburden Testing Business (2016-2021)
Figure 58. Sigma-Aldrich Revenue Growth Rate in Bioburden Testing Business (2016-2021)
Figure 59. SGS Revenue Growth Rate in Bioburden Testing Business (2016-2021)
Figure 60. Wuxi Pharmatech (CAYMAN) Revenue Growth Rate in Bioburden Testing Business (2016-2021)
Figure 61. Merck Revenue Growth Rate in Bioburden Testing Business (2016-2021)
Figure 62. Becton Dickinson Revenue Growth Rate in Bioburden Testing Business (2016-2021)
Figure 63. North American Science Associates Inc. Revenue Growth Rate in Bioburden Testing Business (2016-2021)
Figure 64. Nelson Laboratories Revenue Growth Rate in Bioburden Testing Business (2016-2021)
Figure 65. Pacific Biolabs Revenue Growth Rate in Bioburden Testing Business (2016-2021)
Figure 66. ATS Labs Revenue Growth Rate in Bioburden Testing Business (2016-2021)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
世界のバイオモニタリング・バイオバーデン試験市場規模・現状・予測（2021年-2027年） Biomonitoring is a simple process its of two type, the very first one is to check the toxic level before and after the project is completed and the other one is the proper checking of all the valid regulation and parameter for the project and maintained the guideline. Bioburden are refer as the numb…- 世界のバイオモニタリング・バイオバーデン試験市場規模・現状・予測（2021年-2027年） Biomonitoring is a simple process its of two type, the very first one is to check the toxic level before and after the project is completed and the other one is the proper checking of all the valid regulation and parameter for the project and maintained the guideline. Bioburden are refer as the numb…
- 世界のバイオバーデン試験装置市場 2021：企業別、地域別、種類・用途別 The Bioburden Testing Instrument market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade re…
- 世界の医薬品無菌検査市場 2021：企業別、地域別、種類・用途別 The Pharmaceutical Sterility Testing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trad…
- 世界の生物学的安全性試験市場規模・現状・予測（2021年-2027年） Biologics are advanced drugs used in treatment of cancer, rheumatoid arthritis, and other diseases. These biologics constitutes large molecules such as monoclonal antibodies, recombinant proteins and their safety ensures patient safety as these are used in the treatment of different diseases. Market…